Literature DB >> 33553435

Risk Factors in Patients with Diabetes Hospitalized for COVID-19: Findings from a Multicenter Retrospective Study.

Yili Zhang1, Juan Wang1, Nannan Tan1, KangJia Du1, Kuo Gao1, Jiacheng Zuo1, Xiaoguang Lu1, Yan Ma2, Yong Hou3, Quntang Li4, Hongming Xu5, Jin Huang6, Qiuhua Huang6, Hui Na7, Jingwei Wang7, Xiaoyan Wang8, Yanhua Xiao9, Junteng Zhu10, Hong Chen11, Zhang Liu12, Mingxuan Wang13, Linsong Zhang14, Shuzhen Guo1, Wei Wang1.   

Abstract

METHODS: In this multicenter retrospective study, patients with COVID-19 in China were included and classified into two groups according to whether they were complicated with diabetes or not. Demographic symptoms and laboratory data were extracted from medical records. Univariable and multivariable logistic regression methods were used to explore the risk factors.
RESULTS: 538 COVID-19 patients were finally included in this study, of whom 492 were nondiabetes and 46 were diabetes. The median age was 47 years (IQR 35.0-56.0). And the elderly patients with diabetes were more likely to have dry cough, and the alanine aminotransferase, lactate dehydrogenase, Ca, and mean hemoglobin recovery rate were higher than the other groups. Furthermore, we also found the liver and kidney function of male patients was worse than that of female patients, while female cases should be paid more attention to the occurrence of bleeding and electrolyte disorders. Moreover, advance age, blood glucose, gender, prothrombin time, and total cholesterol could be considered as risk factors for COVID-19 patients with diabetes through the multivariable logistic regression model in our study.
CONCLUSION: The potential risk factors found in our study showed a major piece of the complex puzzle linking diabetes and COVID-19 infection. Meanwhile, focusing on gender and age factors in COVID-19 patients with or without diabetes, specific clinical characteristics, and risk factors should be paid more attention by clinicians to figure out a targeted intervention to improve clinical efficacy worldwide.
Copyright © 2021 Yili Zhang et al.

Entities:  

Mesh:

Year:  2021        PMID: 33553435      PMCID: PMC7847355          DOI: 10.1155/2021/3170190

Source DB:  PubMed          Journal:  J Diabetes Res            Impact factor:   4.011


  34 in total

Review 1.  Diabetes mellitus as a prothrombotic condition.

Authors:  P J Grant
Journal:  J Intern Med       Date:  2007-08       Impact factor: 8.989

2.  Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection.

Authors:  Kirsten A Kulcsar; Christopher M Coleman; Sarah E Beck; Matthew B Frieman
Journal:  JCI Insight       Date:  2019-10-17

Review 3.  Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections.

Authors:  Kelly Hodgson; Jodie Morris; Tahnee Bridson; Brenda Govan; Catherine Rush; Natkunam Ketheesan
Journal:  Immunology       Date:  2015-02       Impact factor: 7.397

4.  Protective regulation of the ACE2/ACE gene expression by estrogen in human atrial tissue from elderly men.

Authors:  A Bukowska; L Spiller; C Wolke; U Lendeckel; S Weinert; J Hoffmann; P Bornfleth; I Kutschka; A Gardemann; B Isermann; A Goette
Journal:  Exp Biol Med (Maywood)       Date:  2017-06-29

Review 5.  Proteolytic activation of the SARS-coronavirus spike protein: cutting enzymes at the cutting edge of antiviral research.

Authors:  Graham Simmons; Pawel Zmora; Stefanie Gierer; Adeline Heurich; Stefan Pöhlmann
Journal:  Antiviral Res       Date:  2013-10-08       Impact factor: 5.970

6.  Cholesterol: A new game player accelerating vasculopathy caused by SARS-CoV-2?

Authors:  Xiaoling Cao; Rong Yin; Helmut Albrecht; Daping Fan; Wenbin Tan
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-06-05       Impact factor: 4.310

7.  COVID-19-Associated dyslipidemia: Implications for mechanism of impaired resolution and novel therapeutic approaches.

Authors:  Alexander V Sorokin; Sotirios K Karathanasis; Zhi-Hong Yang; Lita Freeman; Kazuhiko Kotani; Alan T Remaley
Journal:  FASEB J       Date:  2020-06-26       Impact factor: 5.191

8.  Can We Reduce Mortality of COVID-19 if We do Better in Glucose Control?

Authors:  Mingyan Deng; Ling Jiang; Yan Ren; Jiayu Liao
Journal:  Med Drug Discov       Date:  2020-06-02

9.  Clinical characteristics and outcomes of patients with severe covid-19 with diabetes.

Authors:  Yongli Yan; Yan Yang; Fen Wang; Huihui Ren; Shujun Zhang; Xiaoli Shi; Xuefeng Yu; Kun Dong
Journal:  BMJ Open Diabetes Res Care       Date:  2020-04

Review 10.  The sweeter side of ACE2: physiological evidence for a role in diabetes.

Authors:  Sharell M Bindom; Eric Lazartigues
Journal:  Mol Cell Endocrinol       Date:  2008-10-01       Impact factor: 4.102

View more
  4 in total

Review 1.  Diabetes and SARS-CoV-2-Is There a Mutual Connection?

Authors:  Anna P Jedrzejak; Edyta K Urbaniak; Jadwiga A Wasko; Natalia Ziojla; Malgorzata Borowiak
Journal:  Front Cell Dev Biol       Date:  2022-06-13

2.  Serum level estimation of some biomarkers in diabetic and non-diabetic COVID-19 infected patients.

Authors:  Muhammad Usman Faryad Khan; Baida Rihan Ali; Husham Qassim Mohammed; Hayder Mohammed Thyab Al-Shammari; Abduladheem Turki Jalil; Nada Khazal Kadhim Hindi; Wanich Suksatan; Balsam Qubais Saeed; Rasha Fadhel Obaid; Marwan Mahmood Saleh; Mustafa M Kadhim
Journal:  Appl Nanosci       Date:  2022-02-03       Impact factor: 3.674

Review 3.  Role of Dipeptidyl Peptidase-4 (DPP4) on COVID-19 Physiopathology.

Authors:  Alba Sebastián-Martín; Belén G Sánchez; José M Mora-Rodríguez; Alicia Bort; Inés Díaz-Laviada
Journal:  Biomedicines       Date:  2022-08-19

4.  Mortality Rate of Patients With COVID-19 Based on Underlying Health Conditions.

Authors:  Won-Young Choi
Journal:  Disaster Med Public Health Prep       Date:  2021-05-03       Impact factor: 1.385

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.